Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)
International Journal of Oncology · 29.02.2024 · 64 (4)
DOI: 10.3892/ijo.2024.5632 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 29.02.2024. Verfasst von Jinzhe Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Division of Thoracic Neoplasms, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Butyrates, Neoplasms. Die Arbeit wurde bisher 151-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Division of Thoracic Neoplasms, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China.
- Department of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China.
Zitieren
APA
Sun, J., Chen, S., Zang, D., Sun, H., Sun, Y., & Chen, J. (2024). Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review). International Journal of Oncology, 64(4). https://doi.org/10.3892/ijo.2024.5632
Vancouver
Sun J, Chen S, Zang D, Sun H, Sun Y, Chen J. Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review). International Journal of Oncology. 2024;64(4). doi:10.3892/ijo.2024.5632
BibTeX
@article{Sun2024,
author = {Sun, Jinzhe and Chen, Shiqian and Zang, Dan and Sun, Hetian and Sun, Yan and Chen, Jun},
title = {Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)},
journal = {International Journal of Oncology},
year = {2024},
volume = {64},
number = {4},
doi = {10.3892/ijo.2024.5632}
}
EUVIMED